BonowRO, CarabelloBA, ChatterjeeK. ACC/AHA guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Disease). J Am Coll Cardiol2006;48:e1–148.
2.
AnsellJ, HirshJ, PollerL. The pharmacology and management of the vitamin K antagonists: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest2004;126(3 suppl):204S–33S.
3.
KovacsMJ, KearonC, RodgerM. Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin. Circulation2004;110:1658–63.
4.
SpandorferJM, LynchS, WeitzHH, FertelS, MerliGJ. Use of enoxaparin for the chronically anticoagulated patient before and after procedures. Am J Cardiol1999;84:478–80.
5.
DunnA.Perioperative management of oral anticoagulation: when and how to bridge. J Thromb Thrombolysis2006;21:85–9.
